Biotechnology Business for Sale in Benavente, Portugal
Established | 1-5 year(s) |
Employees | 10 - 50 |
Legal Entity | Other |
Reported Sales | USD 1.3 million |
Run Rate Sales | Nil |
EBITDA Margin | Nil |
Industries | Biotechnology |
Locations | Benavente |
Local Time | 9:56 PM Europe / Dublin |
Listed By | Management Member |
Status | Active |
- Technologically advanced biotech group, consisting of 2 Portuguese companies supplying tissue-cultured genetics and lab analytical services, as well as controlled substances storage and distribution (operational), GMP processing, and API extraction (Active Pharmaceutical ingredients) upon successful GMP inspection (pending).
- Founders collectively have 60+ years of experience in pharmaceuticals and designed the facility to perform a wide range of technical support & contract manufacturing services.
- Founders have jointly achieved 8 licenses in their previous ventures (GACP / GMP); GACP & GDP license achieved, GMP application satisfactory, pending license inspection by Infarmed.
- Distribution partnership agreement in place with Segra International Corp. for tissue culture genetics:
An exclusivity agreement is in place to sell 27 genetics with an additional 50 new coming online.
- Facility harvesting electricity via PV panels and storing it in its own battery energy storage system.
- The company is fully operational, currently, the main operational activity is tuned down to prepare the sale.
- Sale of certified clean genetics/clones (tissue culture) (operational)
- Processing services: cryogenic freezing (operational)
- Lab services: pharmaceutical standard lab with HPLC, rt qPCR. (operational)
- GMP processing services: drying, sanitization, curing, packaging, white labeling, GMP storage (pending)
- GMP management services: product registrations, product releases, stability studies. (pending)
- Manufacturing and supply of extractions/isolates of APIs (active pharmaceutical ingredients): We manufacture tailor-made API products to our clients' required specifications (in-house solventless extraction technology) (pending).
Currently, the facility is almost finalized in fit-out, with the following assets (including but not limited to; some assets in the list that are owned in quantities higher than 1):
Extraction vessel with saw blade & driver.
Desiccant air control unit.
Stainless steel drying cars and trays.
Extraction and transfer pump.
Fogger with extension.
Packaging machine with multi-head weigher and work platform.
Julabo - temperature control units.
6 additional temperature control units.
Mobile manufacturing reactor 100L.
Stainless steel pneumatic pump.
GMP electrical power board.
Decanter & control unit.
1000L storage vessel.
700L storage vessel.
80L high-pressure mobile reactor.
Full ethanol extraction line.
Short path distillation unit.
GAFF filter system.
PPR HVAC lines (various sizes).
Dehumidifier.
Grinder Robo Coup.
Ultrasonic washer.
Pallet scales.
Standby generator 400KW.
Kosh store.
Fire tank & pump station.
Cryogenic freezer, containment & safety features.
Temp chiller.
Portable containers.
2000L jacketed vessel.
Reverse osmosis system.
OKI boiler.
Various irrigation tanks & pumps.
Cultivation grow system (lights, benches, fans, CO2, scales, ACs, etc)
Electric forklift.
Main chiller & free cooling.
Air handling units & fans.
Turbo extraction fan.
2x large-scale manufacturing ultrasonic probes.
Chromatography prep. (manufacturing)
2x Chromatography analytical (Agilent HPLC/DAD & Fluorescence detection)
Agilent PCR.
Agilent GCMS.
2x Laminar flow hood.
Heidolph 20L rotary evaporator.
50L rotary evaporator with glassware.
Food grade flow sensor.
API fridge in GMP.
Freezer in the warehouse.
Security cameras, sensors, headend system, perimeter beams, etc.
PV panels 45kWh.
Energy storage system 90kWh includes inverters etc.
Office equipment.
The facility is 30 minutes from Lisbon Airport.
The company’s facility is established to carry out GACP, GDP & EU-GMP operations. The facility is designed to ensure regulatory compliance for our pharmaceutical manufacturing areas to ensure the optimization of our processes and workflows. Our existing cleanroom and licensed cultivation areas are fully automated and engineered to control the climate conditions including humidity, heating, and cooling; watering and optimal lighting considerations to ensure quality and safety. High-tech security systems have been installed all throughout the building to maintain effective control and supervision of all operations, this includes access control on all doors, CCTV, alarm sensors internally and along the perimeter of the building.
Building breakdown area sizes:
- Total plot of land (8C): 3487.75 meters squared- leased land.
- Total building size: 1316.32 meters squared (excluding first Floor space 750.44 meters squared). Total including ground & first floor = 2066.76 meters squared. (Not including containers)
- Total container space: 285.15 meters squared.
- Total useable space: 2351.91 (Ground floor + First Floor + containers)
- Subsidiary 1 area: 730.88 meters squared. (operational)
- Subsidiary 2 area: 967.32 meters squared. (Ground floor & first floor)
- GACP cultivation area: 113.47 meters squared.
- GDP wholesale warehouse: 48.59 meters squared.
- GACP labs area: 74.4 meters squared.
- Cryogenic freezing operations: 63.98 meters squared.
Subsidiary 1 -
Bank debt:
- Loan: € 524,761.
- Overdraft: € 350,000.
- Liquid guarantee bank deposit in cash of € 274,500.
- Total bank debt: € 600,261.
Bank debt service:
- Loan capital & interests € 12,600 per month.
- Overdraft Interests € 2120 per month.
- Total bank debt service per month: € 14,720.
Subsidiary 2 -
Bank debt:
- Loan: € 2,476,174.
- Leasing: € 2,157.576.
- Total bank debt: € 4,633,750.
Bank debt service:
- Loan interests € 12,000 per month + +/- € 270,000 capital every 6 months.
- Leasings € 75,000 per month.
Tax benefits:
- €2.1M end of last year to be deducted from profits in the coming 8/9 years.
- €700k to date, to be deducted in the coming 10 years.
Total: €2.8M tax benefits.
* No outstanding liabilities; insurance, taxes, and social security are all updated and complied with.
-
Earlier than 15 daysDirector, Biotech / Pharma, Chicago, Corporate Investor / Buyer connected with the Business
-
Earlier than 15 daysChairman, Lisbon, M&A Advisor connected with the Business
-
Earlier than 15 daysBoard Member, Mental Healthcare Services, Paris, Individual Investor / Buyer connected with the Business